HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Tóth Selected Research

Irinotecan (Camptosar)

4/2006Potentiation of irinotecan sensitivity by Se-methylselenocysteine in an in vivo tumor model is associated with downregulation of cyclooxygenase-2, inducible nitric oxide synthase, and hypoxia-inducible factor 1alpha expression, resulting in reduced angiogenesis.
2/2000Overexpression of Bax enhances antitumor activity of chemotherapeutic agents in human head and neck squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Tóth Research Topics

Disease

6Neoplasms (Cancer)
08/2014 - 02/2000
2Carcinoma (Carcinomatosis)
02/2010 - 12/2000
2Squamous Cell Carcinoma of Head and Neck
04/2006 - 02/2000
1Glioma (Gliomas)
08/2014
1Glioblastoma (Glioblastoma Multiforme)
08/2014
1Colonic Neoplasms (Colon Cancer)
02/2010
1Adenoma (Adenomas)
02/2010
1Colorectal Neoplasms (Colorectal Cancer)
02/2010
1Seizures (Absence Seizure)
01/2007
1Graves Ophthalmopathy
06/2006
1Hypoxia (Hypoxemia)
04/2006
1Photosensitivity Disorders (Photodermatitis)
12/2003
1Ischemia
10/2001
1Cardiovascular Diseases (Cardiovascular Disease)
10/2001
1Melanoma (Melanoma, Malignant)
06/2001
1Cardiotoxicity
01/2001

Drug/Important Bio-Agent (IBA)

2LigandsIBA
08/2014 - 06/2001
2Irinotecan (Camptosar)FDA LinkGeneric
04/2006 - 02/2000
2raltitrexed (D 1694)IBA
12/2000 - 02/2000
1SugarsIBA
08/2014
1GoldIBA
08/2014
1gold chlorideIBA
08/2014
1Carmustine (FIVB)FDA Link
08/2014
1Glucose (Dextrose)FDA LinkGeneric
08/2014
1DisulfidesIBA
08/2014
1Oxidoreductases (Dehydrogenase)IBA
08/2014
1RetinoidsIBA
05/2011
1GlucocorticoidsIBA
05/2011
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
02/2010
1Glucagon (Glukagon)FDA Link
02/2010
1claudin 8IBA
02/2010
1N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA
02/2010
1Messenger RNA (mRNA)IBA
02/2010
1Peptide YYIBA
02/2010
1Cadherins (E-Cadherin)IBA
02/2010
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
01/2007
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
04/2006
1selenomethylselenocysteine (methylselenocysteine)IBA
04/2006
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2006
1PorphyrinsIBA
12/2003
1Carvedilol (Coreg)FDA LinkGeneric
10/2001
1Free RadicalsIBA
10/2001
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2001
1Peroxynitrous Acid (Peroxynitrite)IBA
10/2001
1PhosphoserineIBA
06/2001
1Lipoxygenase (Lipoxygenase-1)IBA
06/2001
1Fibrinogen (Factor I)FDA Link
06/2001
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
06/2001
1baicaleinIBA
06/2001
112-Hydroxy-5,8,10,14-eicosatetraenoic AcidIBA
06/2001
1Monoclonal AntibodiesIBA
06/2001
1calphostin CIBA
06/2001
1Proteins (Proteins, Gene)FDA Link
06/2001
1Serine (L-Serine)FDA Link
06/2001
1Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA
06/2001
1Platelet Glycoprotein GPIIb-IIIa ComplexIBA
06/2001
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2001
1Anti-Bacterial Agents (Antibiotics)IBA
01/2001
1AntioxidantsIBA
01/2001
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
02/2000

Therapy/Procedure

2Therapeutics
05/2011 - 01/2001
1Chemoprevention
02/2010
1Decompression
06/2006
1Lipectomy (Liposuction)
06/2006
1Aftercare (After-Treatment)
04/2006
1Ligation
06/2001